Clinical Trial Update: Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating Bryostatin 1 in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED